Silica-coated Calcium Pectinate Beads for Colonic Drug Delivery
Overview
Affiliations
The aim of this work is to develop novel organic-inorganic hybrid beads for colonic drug delivery. For this purpose, calcium pectinate beads with theophylline are prepared by a cross-linking reaction between amidated low-methoxyl pectin and calcium ions. The beads are then covered with silica, starting from tetraethyoxysilane (TEOS), by a sol-gel process. The influence of TEOS concentration (0.25, 0.50, 0.75 and 1.00 M) during the process is studied in order to modulate the thickness of the silica layer around the pectinate beads and thus to control the drug release. The interactions between the silica coating and the organic beads are weak according to the physicochemical characterizations. A good correlation between physicochemical and in-vitro dissolution tests is observed. At concentrations of TEOS beyond 0.25 M, the silica layer is thick enough to act as a barrier to water uptake and to reduce the swelling ratio of the beads. The drug release is also delayed. Silica-coated pectinate beads are promising candidates for sustained drug delivery systems.
Pectin hydrogels for controlled drug release: Recent developments and future prospects.
Kapoor D, Garg R, Gaur M, Pareek A, Prajapati B, Castro G Saudi Pharm J. 2024; 32(4):102002.
PMID: 38439951 PMC: 10910345. DOI: 10.1016/j.jsps.2024.102002.
Chitosan and Pectin Hydrogels for Tissue Engineering and In Vitro Modeling.
Morello G, De Iaco G, Gigli G, Polini A, Gervaso F Gels. 2023; 9(2).
PMID: 36826302 PMC: 9957157. DOI: 10.3390/gels9020132.
Fibrin-Rhamnogalacturonan I Composite Gel for Therapeutic Enzyme Delivery to Intestinal Tumors.
Faizullin D, Valiullina Y, Salnikov V, Zelenikhin P, Zuev Y, Ilinskaya O Int J Mol Sci. 2023; 24(2).
PMID: 36674440 PMC: 9862006. DOI: 10.3390/ijms24020926.
Rhamnogalacturonan-I Based Microcapsules for Targeted Drug Release.
Svagan A, Kusic A, De Gobba C, Larsen F, Sassene P, Zhou Q PLoS One. 2016; 11(12):e0168050.
PMID: 27992455 PMC: 5167381. DOI: 10.1371/journal.pone.0168050.
Optimizing nanomedicine pharmacokinetics using physiologically based pharmacokinetics modelling.
Moss D, Siccardi M Br J Pharmacol. 2014; 171(17):3963-79.
PMID: 24467481 PMC: 4243971. DOI: 10.1111/bph.12604.